CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on developing innovative RNA delivery systems for treating pulmonary diseases. By utilizing nano-embedded microparticles, it aims to create inhalable RNA therapeutics, specifically targeting allergic asthma, while also establishing a scalable production technology for RNA-loaded dry powders.
One of the main challenges in the domain of respiratory RNA delivery has been administration.
Today, while 15 RNA therapeutics areundergoing clinical trials for pulmonary diseases, none has yet secured regulatory approval.
Our nano-embedded microparticles(NEMs) represent a disruptive approach and paradigm shift in the field of RNA therapeutics for the treatment pulmonary diseases.
OurIP-protected NEM technology comprises therapeutic RNA, which is encapsulated in lipid nanoparticles (LNPs) and fo…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
